Extent of margin positivity as a predictor for local recurrence after breast conserving irradiation

Radiation Oncology Investigations

Volumn 7, Issue 2, 1999, Pages 111-117

  Wazer, David E ^a,c   Jabro, Gina ^a   Ruthazer, Robin ^a   Schmid, Chris ^a   Safaii, Homa ^a   Schmidt Ullrich, Rupert K ^a,b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TUFTS MEDICAL CENTER   (United States)

Author keywords

Breast carcinoma; Excision margin; Radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER RADIOTHERAPY; CANCER RECURRENCE; FEMALE; FOLLOW UP; HEALTH CARE POLICY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INCIDENCE; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, HORMONAL; BIOPSY; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; FOLLOW-UP STUDIES; HUMANS; MASTECTOMY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; TAMOXIFEN;

EID: 0032959769     PISSN: 10657541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6823(1999)7:2<111::AID-ROI7>3.0.CO;2-U     Document Type: Article

References (14)

1. Wazer DE, Schmidt-Ullrich RK, Schmid C, Ruthazer R, Kramer B, Safaii H, Graham R. The value of breast lumpectomy margin assessment as a predictor of residual tumor burden. Int J Radiat Oncol Biol Phys 1997;38:291-299.
2. Wazer DE, Schmidt-Ullrich RK, Ruthazer R, Schmid C, Graham R, Safaii H, Rothschild J, McGrath J, Erban JK. Factors determining outcome for breast conserving irradiation with margin-directed dose escalation to the tumor bed. Int J Radiat Oncol Biol Phys 1998;40:851-858.
3. Schmidt-Ullrich R, Wazer DE, Tercilla O, Safaii H, Marchant DJ, Smith TJ, Homer M, Robert NJ. Tumor margin assessment as a guide to optimal conservation surgery and irradiation in early stage breast carcinoma. Int J Radiat Oncol Biol Phys 1989;17:733-738.
4. Schmidt-Ullrich R, Wazer DE, DiPetrillo T, Marchant DJ, Smith TJ, Safaii H, Schmid C, Homer M. Breast conservation therapy for early stage breast carcinoma with outstanding 10-year locoregional control rates: A case for aggressive therapy to the tumor-bearing quadrant. Int J Radiat Oncol Biol Phys 1993;27:545-552.
5. Holland R, Connolly JL, Gelman R, Mravunac M, Hendriks JHCL, Verbeek ALM, Schnitt SL, Silver B, Boyages J, Harris JR. The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast. J Clin Oncol 1990;8:113-118.
6. Schnitt SJ, Connolly JL, Harris JR, Hellman S, Cohen RB. Pathologic predictors of early local recurrence in stage I and II breast cancer treated by primary radiation therapy. Cancer 1984;53:1049-1057.
7. Wazer DE, Kramer B, Schmid C, Ruthazer R, Ulin K, Schmidt-Ullrich R. Factors determining outcome in patients treated with interstitial implantation as a radiation boost for breast conservation therapy. Int J Radiat Oncol Biol Phys 1997;39:381-393.
8. Zwicker RD, Schmidt-Ullrich RK, Schiller B. Planning of Ir-192 seed implants for boost irradiation to the breast. Int J Radiat Oncol Biol Phys 1985;11:2163-2170.
9. Holland R, Veling SHJ, Mravunac M, Hendriks JHCL. Histologic multifocality of Tis, T1-2 breast carcinomas. Cancer 1985;56:979-990.
10. DiBiase SJ, Komarnicky LT, Schwartz GF, Xie Y, Mansfield CM. The number of positive margins influences the outcome of women treated with breast preservation for early stage breast carcinoma. Cancer 1998; 82:2212-2220.
11. Gage I, Schnitt SJ, Nixon AJ, Silver B, Recht A, Troyan SL, et al. Pathologic margin involvement and the risk of recurrence in patients treated with breast-conserving therapy. Cancer 1996;78:1921-1928.
12. Solin U, Fowble BL, Schultz DJ, Goodman RL. The significance of the pathology margins of the tumor excision on the outcome of patients treated with definitive irradiation for early stage breast cancer. Int J Radiat Oncol Biol Phys 1991;21:279-287.
13. Turner BC, Haffty BG, Narayanan L, Yuan J, Havre PA, Gumbs AA, Kaplan L, Burgard J, Carter D, Baserga R, Glazer PM. Insulin-like growth factor-I receptor overexpression mediates cellular radioresistance and local breast cancer recurrence after lumpectomy and radiation. Cancer Res 1997;57:3079-3083.
14. Deng G, Lu Y, Zlotnikov G, Thor A, Smith HS. Loss of heterozygosity in normal tissue adjacent to breast carcinomas. Science 1996;274:2057-2059.